Picture of Bayer AG logo

BAYN Bayer AG News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareAdventurousLarge CapNeutral

REG - Secured Fixed Income - Director Dealing

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260310:nRSJ0853Wa&default-theme=true

RNS Number : 0853W  Secured Fixed Income PLC  10 March 2026

10 March 2026

SECURED FIXED INCOME PLC

DIRECTOR DEALING

Secured Fixed Income plc (the "Company") announces that it has been informed
that Michael Bayer, a director of the Company, has subscribed for £20,000 of
the 7.5 per cent. sterling-denominated bonds due 2029 to be issued by the
Company on 16 March 2026 as further set out in the table below.

This announcement is made in accordance with the requirements of Article 19 of
the Market Abuse Regulation (EU) No. 596/2014, as it forms part of UK domestic
law by virtue of the European Union (Withdrawal) Act 2018.

 

 1.                                          Details of the person discharging managerial responsibilities/person closely
                                             associated
 a)                                          Name:                                                         Michael Bayer
 2.                                          Reason for the notification
 a)                                          Position/status:                                              Director
 b)                                          Initial notification/Amendment:                               Initial notification
 3.                                          Details of the issuer, emission allowance market participant, auction
                                             platform, auctioneer or auction monitor
 a)                                          Name:                                                         Secured Fixed Income plc
 b)                                          LEI:                                                          213800QYGGGQ4NU23915
 4.                                          Details of the transaction(s): section to be repeated for (i) each type of
                                             instrument; (ii) each type of transaction; (iii) each date; and (iv) each
                                             place where transactions have been conducted
 a)                                          Description of the financial instrument, type of instrument:   7.5 per cent. Bonds due 2029

                                             Identification code:                                          XS3273290497
 b)                                          Nature of the transaction:                                    Purchase of bonds
 c)                                          Price(s) and volume(s):                                       Price: 100 per cent.

                                                                                                           Volume: £20,000
 d)                                          Aggregated information:

                                             ·  Aggregated volume:                                         n/a

                                             ·  Price:
 e)                                          Date of the transaction:                                      2026-03-09
 f)                                          Place of the transaction:                                     Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHBDGDXRBBDGLG



            Copyright 2019 Regulatory News Service, all rights reserved

Recent news on Bayer AG

See all news